Integrity Applications Ltd

P.O. Box 12163, 7760049 Ashdod
19 Häyahalomim st., Ashdod

Telephone +972 8 6757878
Fax +972 8 6757850

This company is co-exhibitor of
Israel Export & International Cooperation Institute


Hall map

MEDICA 2016 hall map (Hall 16): stand G40

Fairground map

MEDICA 2016 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.08  Devices and systems for glucose determination units

Devices and systems for glucose determination units

Our products

Product category: Devices and systems for glucose determination units


GlucoTrack gives you freedom from finger-pricking to help you manage your diabetes

GlucoTrack is battery-operated and includes a Main Unit (MU), which contains display and control features, as well as transmitter, receiver and processor, and a Personal Ear Clip (PEC), which is clipped to the earlobe and contains sensors and calibration electronics.

The device is small, light and easy to use and handle. The Main Unit can be shared by up to three users (in model DF-F), although each user requires his/her own (individually calibrated) PEC. The device includes a USB port for data downloading (enables off-line analysis), as well as battery recharging.

More Less

About us

Company details

Integrity Applications (OTCQB: IGAP) has developed a non-invasive glucose monitor for self-use, GlucoTrack®, which utilizes patented combination of ultrasonic, electromagnetic and thermal technologies, measuring three criteria, to provide glucose measurement. By removing the two most significant barriers, pain and cost, GlucoTrack enables type 2 diabetics and pre-diabetics to measure their glucose levels frequently, without drawing blood. A small sensor clips comfortably to the earlobe, while glucose level is calculated, using a proprietary algorithm and displayed on hand held device, the size of a smart phone.

Integrity Applications’ GlucoTrack model DF-F has been proven for safety and performances in clinical studies, conducted by third party, under the supervision of leading diabetes authorities at the Soroka University Medical Center in Israel. The upgraded device has gained CE-Mark approval in December 2015.

More Less

Company data

Number of employees




Area of business

Electromedical equipment / Medical Technology